Nutritional supplement for body fat reduction
The present invention is directed to compositions containing a conjugated linoleic acid derivative, a banaba extract and an extract of Phaseolis vulgaris and methods of treatment for weight loss.
1 . A composition comprising a banaba extract, a conjugated linoleic acid derivative and a starch blocker.
2 . The composition of claim 1 , wherein said banaba extract is from Lagerstroemia Speciosa L.
3 . The composition of claim 1 , wherein said banaba extract comprises 3% corosolic acid by weight.
4 . The composition of claim 1 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
5 . The composition of claim 1 , wherein said starch blocker is an alpha amylase inhibitor.
6 . The composition of claim 1 , wherein said starch blocker is derived from Phaseolis vulgaris.
7 . A method to reduce body fat, comprising the step of ingesting a composition comprising a banaba extract, a conjugated linoleic acid derivative and a starch blocker.
8 . The method of claim 7 , wherein said banaba extract is from Lagerstroemia Speciosa L.
9 . The method of claim 7 , wherein said banaba extract comprises 3% corosolic acid by weight.
10 . The method of claim 7 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
13 . The method of claim 7 , wherein said starch blocker is an alpha amylase inhibitor.
14 . The method of claim 7 , wherein said starch blocker is derived from Phaseolis vulgaris.
15 . A packaged nutraceutical for reducing body fat, comprising a composition comprising a banaba extract, a conjugated linoleic acid derivative and a starch blocker; and
instructions for administering said fat reducing composition.
16 . The packaged nutraceutical of claim 15 , wherein said banaba extract is from Lagerstroemia Speciosa L.
17 . The packaged nutraceutical of claim 15 , wherein said banaba extract comprises 3% corosolic acid by weight.
18 . The packaged nutraceutical of claim 15 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
19 . The packaged nutraceutical of claim 15 , wherein said starch blocker is an alpha amylase inhibitor.
20 . The packaged nutraceutical of claim 15 , wherein said starch blocker is derived from Phaseolis vulgaris.
21 . A method to increase glucose metabolism, comprising the step of ingesting a composition comprising a banaba extract, a conjugated linoleic acid derivative and a starch blocker.
22 . The method of claim 21 , wherein said banaba extract is from Lagerstroemia Speciosa L.
23 . The method of claim 21 , wherein said banaba extract comprises 3% corosolic acid by weight.
24 . The method of claim 21 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
25 . The method of claim 21 , wherein said starch blocker is an alpha amylase inhibitor.
26 . The method of claim 21 , wherein said starch blocker is derived from Phaseolis vulgaris.
27 . A packaged nutraceutical for increasing glucose metabolism, comprising a composition comprising a banaba extract, a conjugated linoleic acid derivative and a starch blocker; and
instructions for administering said glucose metabolism increasing composition.
28 . The packaged nutraceutical of claim 27 , wherein said banaba extract is from Lagerstroemia Speciosa L.
29 . The packaged nutraceutical of claim 27 , wherein said banaba extract comprises 3% corosolic acid by weight.
30 . The packaged nutraceutical of claim 27 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
31 . The packaged nutraceutical of claim 27 , wherein said starch blocker is an alpha amylase inhibitor.
32 . The packaged nutraceutical of claim 27 , wherein said starch blocker is derived from Phaseolis vulgaris.
33 . A method to inhibit metabolism of carbohydrates, comprising the step of ingesting a composition comprising a banaba extract, a conjugated linoleic acid derivative and a starch blocker.
34 . The method of claim 33 , wherein said banaba extract is from Lagerstroemia Speciosa L.
35 . The method of claim 33 , wherein said banaba extract comprises 3% corosolic acid by weight.
36 . The method of claim 33 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
37 . The method of claim 33 , wherein said starch blocker is an alpha amylase inhibitor.
38 . The method of claim 33 , wherein said starch blocker is derived from Phaseolis vulgaris.
39 . A packaged nutraceutical for inhibiting metabolism of carbohydrates, comprising a composition comprising a banaba extract, a conjugated linoleic acid derivative and a starch blocker; and
instructions for administering said composition.
40 . The packaged nutraceutical of claim 39 , wherein said banaba extract is from Lagerstroemia Speciosa L.
41 . The packaged nutraceutical of claim 39 , wherein said banaba extract comprises 3% corosolic acid by weight.
42 . The packaged nutraceutical of claim 39 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
43 . The packaged nutraceutical of claim 39 , wherein said starch blocker is an alpha amylase inhibitor.
44 . The packaged nutraceutical of claim 39 , wherein said starch blocker is derived from Phaseolis vulgaris.
45 . A method for weight loss, comprising the step of ingesting a composition comprising a banaba extract, a conjugated linoleic acid derivative and a starch blocker.
46 . The method of claim 45 , wherein said banaba extract is from Lagerstroemia Speciosa L.
47 . The method of claim 45 , wherein said banaba extract comprises 3% corosolic acid by weight.
48 . The method of claim 45 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
49 . The method of claim 45 , wherein said starch blocker is an alpha amylase inhibitor.
50 . The method of claim 45 , wherein said starch blocker is derived from Phaseolis vulgaris.
51 . A packaged nutraceutical for weight loss, comprising a composition comprising a banaba extract, a conjugated linoleic acid derivative and a starch blocker; and
instructions for administering said composition.
52 . The packaged nutraceutical of claim 52 , wherein said banaba extract is from Lagerstroemia Speciosa L.
53 . The packaged nutraceutical of claim 52 , wherein said banaba extract comprises 3% corosolic acid by weight.
54 . The packaged nutraceutical of claim 52 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
55 . The packaged nutraceutical of claim 52 , wherein said starch blocker is an alpha amylase inhibitor.
56 . The packaged nutraceutical of claim 52 wherein said starch blocker is derived from Phaseolis vulgaris.
57 . A soft gel capsule comprising a composition of a banaba extract, a conjugated linoleic acid derivative and a starch blocker encapsulated within said soft gel capsule.
58 . The soft gel capsule of claim 57 , wherein said banaba extract is from Lagerstroemia Speciosa L.
59 . The soft gel capsule of claim 57 , wherein said banaba extract comprises 3% corosolic acid by weight.
60 . The soft gel capsule of claim 57 , wherein the conjugated linoleic acid derivative is conjugated linoleic acid, esters or salts thereof.
61 . The soft gel capsule of claim 57 , wherein said starch blocker is an alpha amylase inhibitor.
62 . The soft gel capsule of claim 57 , wherein said starch blocker is derived from Phaseolis vulgaris.